{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,30]],"date-time":"2026-04-30T08:32:54Z","timestamp":1777537974635,"version":"3.51.4"},"reference-count":49,"publisher":"Elsevier BV","issue":"6","license":[{"start":{"date-parts":[[2018,3,1]],"date-time":"2018-03-01T00:00:00Z","timestamp":1519862400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2018,3,1]],"date-time":"2018-03-01T00:00:00Z","timestamp":1519862400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2019,3,15]],"date-time":"2019-03-15T00:00:00Z","timestamp":1552608000000},"content-version":"vor","delay-in-days":379,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"}],"funder":[{"DOI":"10.13039\/100000002","name":"NIH","doi-asserted-by":"publisher","award":["CA140515"],"award-info":[{"award-number":["CA140515"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"NIH","doi-asserted-by":"publisher","award":["CA183594"],"award-info":[{"award-number":["CA183594"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"NIH","doi-asserted-by":"publisher","award":["CA174786"],"award-info":[{"award-number":["CA174786"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"name":"Clive Davis Research Fellow"},{"name":"Joel A. Katz Music Medicine Fund"},{"name":"T.J. Martell Foundation\/Winship Cancer Institute","award":["3373-18"],"award-info":[{"award-number":["3373-18"]}]},{"name":"The Leukemia and Lymphoma Society"},{"name":"Winship 5K"}],"content-domain":{"domain":["cell.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Molecular Cell"],"published-print":{"date-parts":[[2018,3]]},"DOI":"10.1016\/j.molcel.2018.02.010","type":"journal-article","created":{"date-parts":[[2018,3,15]],"date-time":"2018-03-15T11:44:04Z","timestamp":1521114244000},"page":"923-937.e8","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":19,"title":["The Dietary Supplement Chondroitin-4-Sulfate Exhibits Oncogene-Specific Pro-tumor Effects on BRAF V600E Melanoma Cells"],"prefix":"10.1016","volume":"69","author":[{"given":"Ruiting","family":"Lin","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Siyuan","family":"Xia","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Changliang","family":"Shan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Dong","family":"Chen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yijie","family":"Liu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xue","family":"Gao","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mei","family":"Wang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hee-Bum","family":"Kang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yaozhu","family":"Pan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shuangping","family":"Liu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Young Rock","family":"Chung","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Omar","family":"Abdel-Wahab","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Taha","family":"Merghoub","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Michael","family":"Rossi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ragini R.","family":"Kudchadkar","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"David H.","family":"Lawson","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Fadlo R.","family":"Khuri","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sagar","family":"Lonial","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jing","family":"Chen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.molcel.2018.02.010_bib1","doi-asserted-by":"crossref","first-page":"873","DOI":"10.1038\/nrd3847","article-title":"Vemurafenib: the first drug approved for BRAF-mutant cancer","volume":"11","author":"Bollag","year":"2012","journal-title":"Nat. Rev. Drug Discov."},{"key":"10.1016\/j.molcel.2018.02.010_bib2","doi-asserted-by":"crossref","first-page":"573","DOI":"10.1080\/01635581.2011.553022","article-title":"Specialty supplements and prostate cancer risk in the VITamins and Lifestyle (VITAL) cohort","volume":"63","author":"Brasky","year":"2011","journal-title":"Nutr. Cancer"},{"issue":"Pt A","key":"10.1016\/j.molcel.2018.02.010_bib3","doi-asserted-by":"crossref","first-page":"449","DOI":"10.1016\/j.fct.2016.11.001","article-title":"An overview of herb and dietary supplement efficacy, safety and government regulations in the United States with suggested improvements. Part 1 of 5 series","volume":"107","author":"Brown","year":"2017","journal-title":"Food Chem. Toxicol."},{"key":"10.1016\/j.molcel.2018.02.010_bib4","doi-asserted-by":"crossref","first-page":"858","DOI":"10.1152\/physrev.1988.68.3.858","article-title":"The structure and function of cartilage proteoglycans","volume":"68","author":"Carney","year":"1988","journal-title":"Physiol. Rev."},{"key":"10.1016\/j.molcel.2018.02.010_bib5","doi-asserted-by":"crossref","first-page":"795","DOI":"10.1056\/NEJMoa052771","article-title":"Glucosamine, chondroitin sulfate, and the two in combination for painful knee osteoarthritis","volume":"354","author":"Clegg","year":"2006","journal-title":"N.\u00a0Engl. J. Med."},{"key":"10.1016\/j.molcel.2018.02.010_bib6","first-page":"918","article-title":"Biochemical and pharmacokinetic aspects of oral treatment with chondroitin sulfate","volume":"45","author":"Conte","year":"1995","journal-title":"Arzneimittelforschung"},{"key":"10.1016\/j.molcel.2018.02.010_bib7","doi-asserted-by":"crossref","first-page":"15250","DOI":"10.18632\/oncotarget.3888","article-title":"The c-Jun\/RHOB\/AKT pathway confers resistance of BRAF-mutant melanoma cells to MAPK inhibitors","volume":"6","author":"Delmas","year":"2015","journal-title":"Oncotarget"},{"key":"10.1016\/j.molcel.2018.02.010_bib8","doi-asserted-by":"crossref","first-page":"859","DOI":"10.1016\/j.molcel.2016.10.014","article-title":"Tetrameric Acetyl-CoA Acetyltransferase 1 Is Important for Tumor Growth","volume":"64","author":"Fan","year":"2016","journal-title":"Mol. Cell"},{"key":"10.1016\/j.molcel.2018.02.010_bib9","doi-asserted-by":"crossref","first-page":"390","DOI":"10.1038\/nrclinonc.2013.83","article-title":"Paradoxical oncogenesis--the long-term effects of BRAF inhibition in melanoma","volume":"10","author":"Gibney","year":"2013","journal-title":"Nat. Rev. Clin. Oncol."},{"key":"10.1016\/j.molcel.2018.02.010_bib10","first-page":"1077","article-title":"Phase II study of glucosamine with chondroitin on aromatase inhibitor-associated joint symptoms in women with breast cancer","volume":"21","author":"Greenlee","year":"2013","journal-title":"Support. Care Cancer"},{"key":"10.1016\/j.molcel.2018.02.010_bib11","doi-asserted-by":"crossref","first-page":"78","DOI":"10.1016\/j.yrtph.2006.07.004","article-title":"Risk assessment for glucosamine and chondroitin sulfate","volume":"47","author":"Hathcock","year":"2007","journal-title":"Regul. Toxicol. Pharmacol."},{"key":"10.1016\/j.molcel.2018.02.010_bib12","doi-asserted-by":"crossref","first-page":"335","DOI":"10.1177\/1759720X10383076","article-title":"Chondroitin sulfate in the treatment of osteoarthritis: from in\u00a0vitro studies to clinical recommendations","volume":"2","author":"Henrotin","year":"2010","journal-title":"Ther. Adv. Musculoskelet. Dis."},{"key":"10.1016\/j.molcel.2018.02.010_bib13","doi-asserted-by":"crossref","first-page":"e914","DOI":"10.1038\/cddis.2013.441","article-title":"AEBP1 upregulation confers acquired resistance to BRAF (V600E) inhibition in melanoma","volume":"4","author":"Hu","year":"2013","journal-title":"Cell Death Dis."},{"key":"10.1016\/j.molcel.2018.02.010_bib14","doi-asserted-by":"crossref","first-page":"11396","DOI":"10.1074\/jbc.M707549200","article-title":"Identification of chondroitin sulfate glucuronyltransferase as chondroitin synthase-3 involved in chondroitin polymerization: chondroitin polymerization is achieved by multiple enzyme complexes consisting of chondroitin synthase family members","volume":"283","author":"Izumikawa","year":"2008","journal-title":"J.\u00a0Biol. Chem."},{"key":"10.1016\/j.molcel.2018.02.010_bib15","doi-asserted-by":"crossref","first-page":"280","DOI":"10.1007\/s11864-013-0226-8","article-title":"Update on the targeted therapy of melanoma","volume":"14","author":"Johnson","year":"2013","journal-title":"Curr. Treat. Options Oncol."},{"key":"10.1016\/j.molcel.2018.02.010_bib16","doi-asserted-by":"crossref","first-page":"1145","DOI":"10.1136\/ard.2003.011742","article-title":"EULAR Recommendations 2003: an evidence based approach to the management of knee osteoarthritis: Report of a Task Force of the Standing Committee for International Clinical Studies Including Therapeutic Trials (ESCISIT)","volume":"62","author":"Jordan","year":"2003","journal-title":"Ann. Rheum. Dis."},{"key":"10.1016\/j.molcel.2018.02.010_bib17","doi-asserted-by":"crossref","first-page":"1165","DOI":"10.1172\/JCI40582","article-title":"p90 ribosomal S6 kinase 2 promotes invasion and metastasis of human head and neck squamous cell carcinoma cells","volume":"120","author":"Kang","year":"2010","journal-title":"J.\u00a0Clin. Invest."},{"key":"10.1016\/j.molcel.2018.02.010_bib18","doi-asserted-by":"crossref","first-page":"345","DOI":"10.1016\/j.molcel.2015.05.037","article-title":"Metabolic Rewiring by Oncogenic BRAF V600E Links Ketogenesis Pathway to BRAF-MEK1 Signaling","volume":"59","author":"Kang","year":"2015","journal-title":"Mol. Cell"},{"key":"10.1016\/j.molcel.2018.02.010_bib19","doi-asserted-by":"crossref","first-page":"1464","DOI":"10.1001\/jama.2016.14403","article-title":"Trends in Dietary Supplement Use Among US Adults From 1999-2012","volume":"316","author":"Kantor","year":"2016","journal-title":"JAMA"},{"key":"10.1016\/j.molcel.2018.02.010_bib20","doi-asserted-by":"crossref","first-page":"1140","DOI":"10.1016\/j.nutres.2016.09.001","article-title":"Temporal trends in dietary supplement prescriptions of United States military service members suggest a decrease in pyridoxine and increase in vitamin D supplements from 2005 to 2013","volume":"36","author":"Knapik","year":"2016","journal-title":"Nutr. Res."},{"key":"10.1016\/j.molcel.2018.02.010_bib21","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1016\/S1054-3589(05)53003-5","article-title":"Structure of chondroitin sulfate","volume":"53","author":"Lamari","year":"2006","journal-title":"Adv. Pharmacol."},{"key":"10.1016\/j.molcel.2018.02.010_bib22","doi-asserted-by":"crossref","first-page":"308re8","DOI":"10.1126\/scitranslmed.aad3740","article-title":"Antioxidants can increase melanoma metastasis in mice","volume":"7","author":"Le Gal","year":"2015","journal-title":"Sci. Transl. Med."},{"key":"10.1016\/j.molcel.2018.02.010_bib23","doi-asserted-by":"crossref","first-page":"1484","DOI":"10.1038\/ncb3255","article-title":"6-Phosphogluconate dehydrogenase links oxidative PPP, lipogenesis and tumour growth by inhibiting LKB1-AMPK signaling","volume":"17","author":"Lin","year":"2015","journal-title":"Nat Cell Biol."},{"key":"10.1016\/j.molcel.2018.02.010_bib24","doi-asserted-by":"crossref","first-page":"759","DOI":"10.1016\/0006-291X(74)91022-5","article-title":"Morquio\u2019s syndrome: deficiency of a chondroitin sulfate N-acetylhexosamine sulfate sulfatase","volume":"61","author":"Matalon","year":"1974","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"10.1016\/j.molcel.2018.02.010_bib25","first-page":"533","article-title":"A review of Morquio syndrome","volume":"26","author":"Mikles","year":"1997","journal-title":"Am. J. Orthop."},{"key":"10.1016\/j.molcel.2018.02.010_bib26","doi-asserted-by":"crossref","first-page":"735","DOI":"10.1136\/ard.2006.068882","article-title":"Biochemical basis of the effect of chondroitin sulphate on osteoarthritis articular tissues","volume":"67","author":"Monfort","year":"2008","journal-title":"Ann. Rheum. Dis."},{"key":"10.1016\/j.molcel.2018.02.010_bib27","doi-asserted-by":"crossref","first-page":"2750","DOI":"10.1158\/0008-5472.CAN-10-2954","article-title":"PTEN loss confers BRAF inhibitor resistance to melanoma cells through the suppression of BIM expression","volume":"71","author":"Paraiso","year":"2011","journal-title":"Cancer Res."},{"key":"10.1016\/j.molcel.2018.02.010_bib28","doi-asserted-by":"crossref","first-page":"E536","DOI":"10.1073\/pnas.1418163112","article-title":"BRAF inhibitor resistance mediated by the AKT pathway in an oncogenic BRAF mouse melanoma model","volume":"112","author":"Perna","year":"2015","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"10.1016\/j.molcel.2018.02.010_bib29","doi-asserted-by":"crossref","first-page":"407","DOI":"10.1038\/nrendo.2016.54","article-title":"Dietary supplements and disease prevention - a global overview","volume":"12","author":"Rautiainen","year":"2016","journal-title":"Nat. Rev. Endocrinol."},{"key":"10.1016\/j.molcel.2018.02.010_bib30","first-page":"983","article-title":"Elevated stromal chondroitin sulfate glycosaminoglycan predicts progression in early-stage prostate cancer","volume":"3","author":"Ricciardelli","year":"1997","journal-title":"Clin. Cancer Res."},{"key":"10.1016\/j.molcel.2018.02.010_bib31","doi-asserted-by":"crossref","first-page":"527","DOI":"10.1038\/370527a0","article-title":"Phosphatidylinositol-3-OH kinase as a direct target of Ras","volume":"370","author":"Rodriguez-Viciana","year":"1994","journal-title":"Nature"},{"key":"10.1016\/j.molcel.2018.02.010_bib32","doi-asserted-by":"crossref","first-page":"463","DOI":"10.1111\/j.1432-1033.1985.tb08862.x","article-title":"Two N-acetylgalactosaminyltransferase are involved in the biosynthesis of chondroitin sulfate","volume":"148","author":"Rohrmann","year":"1985","journal-title":"Eur. J. Biochem."},{"key":"10.1016\/j.molcel.2018.02.010_bib33","doi-asserted-by":"crossref","first-page":"221ra15","DOI":"10.1126\/scitranslmed.3007653","article-title":"Antioxidants accelerate lung cancer progression in mice","volume":"6","author":"Sayin","year":"2014","journal-title":"Sci. Transl. Med."},{"key":"10.1016\/j.molcel.2018.02.010_bib34","doi-asserted-by":"crossref","first-page":"6247","DOI":"10.1128\/MCB.22.17.6247-6260.2002","article-title":"Multiple phosphoinositide 3-kinase-dependent steps in activation of protein kinase B","volume":"22","author":"Scheid","year":"2002","journal-title":"Mol. Cell. Biol."},{"key":"10.1016\/j.molcel.2018.02.010_bib35","doi-asserted-by":"crossref","first-page":"27","DOI":"10.3945\/an.116.013516","article-title":"Dietary supplements and risk of cause-specific death, cardiovascular disease, and cancer: a systematic review and meta-analysis of primary prevention trials","volume":"8","author":"Schwingshackl","year":"2017","journal-title":"Adv. Nutr."},{"key":"10.1016\/j.molcel.2018.02.010_bib36","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1080\/15216540214923","article-title":"Biosynthesis of chondroitin\/dermatan sulfate","volume":"54","author":"Silbert","year":"2002","journal-title":"IUBMB Life"},{"key":"10.1016\/j.molcel.2018.02.010_bib37","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1042\/bj2290063","article-title":"Endocytosis and degradation of chondroitin sulphate by liver endothelial cells","volume":"229","author":"Smedsr\u00f8d","year":"1985","journal-title":"Biochem. J."},{"key":"10.1016\/j.molcel.2018.02.010_bib38","doi-asserted-by":"crossref","first-page":"283","DOI":"10.1038\/nrm3330","article-title":"The functions and regulation of the PTEN tumour suppressor","volume":"13","author":"Song","year":"2012","journal-title":"Nat. Rev. Mol. Cell Biol."},{"key":"10.1016\/j.molcel.2018.02.010_bib39","doi-asserted-by":"crossref","first-page":"162","DOI":"10.1124\/dmd.115.066902","article-title":"Pharmacokinetic Interactions between Drugs and Botanical Dietary Supplements","volume":"44","author":"Sprouse","year":"2016","journal-title":"Drug Metab. Dispos."},{"key":"10.1016\/j.molcel.2018.02.010_bib40","doi-asserted-by":"crossref","first-page":"1089","DOI":"10.1016\/j.mcna.2016.04.017","article-title":"Utilization and Safety of Common Over-the-Counter Dietary\/Nutritional Supplements, Herbal Agents, and Homeopathic Compounds for Disease Prevention","volume":"100","author":"Trivedi","year":"2016","journal-title":"Med. Clin. North Am."},{"key":"10.1016\/j.molcel.2018.02.010_bib41","first-page":"1800","article-title":"Relative reciprocity of NRAS and PTEN\/MMAC1 alterations in cutaneous melanoma cell lines","volume":"60","author":"Tsao","year":"2000","journal-title":"Cancer Res."},{"key":"10.1016\/j.molcel.2018.02.010_bib42","doi-asserted-by":"crossref","first-page":"48627","DOI":"10.1074\/jbc.C100556200","article-title":"Phosphorylation of the PTEN tail acts as an inhibitory switch by preventing its recruitment into a protein complex","volume":"276","author":"Vazquez","year":"2001","journal-title":"J.\u00a0Biol. Chem."},{"key":"10.1016\/j.molcel.2018.02.010_bib43","doi-asserted-by":"crossref","first-page":"34","DOI":"10.1002\/humu.23070","article-title":"Chondroitin Sulfate N-acetylgalactosaminyltransferase-1 (CSGalNAcT-1) Deficiency Results in a Mild Skeletal Dysplasia and Joint Laxity","volume":"38","author":"Vodopiutz","year":"2017","journal-title":"Hum. Mutat."},{"key":"10.1016\/j.molcel.2018.02.010_bib44","doi-asserted-by":"crossref","first-page":"439","DOI":"10.1186\/1471-2458-12-439","article-title":"The weight of nations: an estimation of adult human biomass","volume":"12","author":"Walpole","year":"2012","journal-title":"BMC Public Health"},{"key":"10.1016\/j.molcel.2018.02.010_bib45","doi-asserted-by":"crossref","first-page":"4008","DOI":"10.1128\/MCB.19.6.4008","article-title":"Protein kinase B\/Akt participates in GLUT4 translocation by insulin in L6 myoblasts","volume":"19","author":"Wang","year":"1999","journal-title":"Mol. Cell. Biol."},{"key":"10.1016\/j.molcel.2018.02.010_bib46","doi-asserted-by":"crossref","first-page":"3113","DOI":"10.1038\/sj.onc.1206451","article-title":"PTEN signaling pathways in melanoma","volume":"22","author":"Wu","year":"2003","journal-title":"Oncogene"},{"key":"10.1016\/j.molcel.2018.02.010_bib47","doi-asserted-by":"crossref","first-page":"358","DOI":"10.1016\/j.cmet.2016.12.010","article-title":"Prevention of Dietary-Fat-Fueled Ketogenesis Attenuates BRAF V600E Tumor Growth","volume":"25","author":"Xia","year":"2017","journal-title":"Cell Metab."},{"key":"10.1016\/j.molcel.2018.02.010_bib48","doi-asserted-by":"crossref","first-page":"1523","DOI":"10.1016\/S0021-9258(18)93574-X","article-title":"Purification and properties of bacterial chondroitinases and chondrosulfatases","volume":"243","author":"Yamagata","year":"1968","journal-title":"J.\u00a0Biol. Chem."},{"key":"10.1016\/j.molcel.2018.02.010_bib49","doi-asserted-by":"crossref","first-page":"18443","DOI":"10.1073\/pnas.0508988102","article-title":"The oncogenic properties of mutant p110alpha and p110beta phosphatidylinositol 3-kinases in human mammary epithelial cells","volume":"102","author":"Zhao","year":"2005","journal-title":"Proc. Natl. Acad. Sci. USA"}],"container-title":["Molecular Cell"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1097276518301084?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1097276518301084?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,22]],"date-time":"2025-10-22T00:22:42Z","timestamp":1761092562000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1097276518301084"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,3]]},"references-count":49,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2018,3]]}},"alternative-id":["S1097276518301084"],"URL":"https:\/\/doi.org\/10.1016\/j.molcel.2018.02.010","relation":{},"ISSN":["1097-2765"],"issn-type":[{"value":"1097-2765","type":"print"}],"subject":[],"published":{"date-parts":[[2018,3]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"The Dietary Supplement Chondroitin-4-Sulfate Exhibits Oncogene-Specific Pro-tumor Effects on BRAF V600E Melanoma Cells","name":"articletitle","label":"Article Title"},{"value":"Molecular Cell","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.molcel.2018.02.010","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2018 Elsevier Inc.","name":"copyright","label":"Copyright"}]}}